Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Adoption Of Audited Financial Results Of The Company.
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Audited financial results of the company for the half year and year ended on 31st March, 2021 Novateor Research Laboratories Ltd - 542771 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of Statutory Auditors of the company Novateor Research Laboratories Ltd - 542771 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Intimation regarding Resignation of Statutory Auditors of the Company. Novateor Research Laboratories Ltd - 542771 - Shareholding for the Period Ended March 31, 2021
Novateor Research Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here Novateor Research Laboratories Ltd - 542771 - Complaince Certificate From PCS Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
Complaince Certificate from PCS under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended on 31st March, 2021 Novateor Research Laboratories Ltd - 542771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 Novateor Research Laboratories Ltd - 542771 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR), 2015 For The Half Year Ended On 31St March, 2021
Compliance Certificate under Regulation 7(3) of SEBI (LODR), 2015 for the half year ended on 31st March, 2021 Novateor Research Laboratories Ltd - 542771 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Navdeep Subhashbhai MehtaDesignation :- Managing Director / Whole Time Director Novateor Research Laboratories Ltd - 542771 - Outcome Of Meeting Of Independent Directors
The separate meeting of the Independent Directors of the Company as per Regulation 25 of SEBI (LODR), 2015 and Section 149 read with Schedule IV of the Companies Act, 2013was held on Tuesday, 30th March, 2021 at 3:00 P.M. and concluded at 3:45 P.M. at the registered office of the company to consider and discuss the following: 1. To review the performance of non-independent directors and the Board as a whole; 2. To review the performance of the Chairman of the Company; 3. To assess the quality, quantity and timeliness of flow of information between the company management and the Board that is necessary for the Board to effectively and reasonably perform their duties. Novateor Research Laboratories Ltd - 542771 - Closure of Trading Window
As per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Trading Window for trading in the Securities of the Company will remain closed with effect from April 1, 2021 for all the Directors, Designated Persons and their immediate relative(s). The Trading Window will be opened 48 hours after the announcement of the Financial Results for the Half year and year ended on March 31, 2021.